Ryan Lantini1, Ashlee C McGrath2, L A R Stein3, Nancy P Barnett4, Peter M Monti4, Suzanne M Colby5. 1. Center for Alcohol and Addiction Studies, Brown University, Box G-S121, Providence, RI 02912, United States. Electronic address: RyanLantini@live.com. 2. Center for Alcohol and Addiction Studies, Brown University, Box G-S121, Providence, RI 02912, United States. 3. Center for Alcohol and Addiction Studies, Brown University, Box G-S121, Providence, RI 02912, United States; University of Rhode Island, Social Sciences Research Center, Department of Psychology, Kingston, RI 02881, United States; Rhode Island Training School, Cranston, RI 02910, United States. 4. Center for Alcohol and Addiction Studies, Brown University, Box G-S121, Providence, RI 02912, United States; Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, RI 02912, United States. 5. Center for Alcohol and Addiction Studies, Brown University, Box G-S121, Providence, RI 02912, United States; Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, RI 02912, United States; Department of Psychiatry and Human Behavior, Brown University, Providence, RI 02912, United States.
Abstract
INTRODUCTION: Misreporting smoking behavior is common among younger smokers participating in clinical trials for smoking cessation. This study focused on the prevalence of and factors associated with adolescent misreporting of smoking behaviors within the context of a randomized clinical trial for smoking cessation. METHODS:Adolescent smokers (N=129) participated in a randomized clinical trial that compared two brief interventions for smoking cessation. Following the final (6-month) follow-up, a confidential, self-administered exit questionnaire examined the extent to which participants admitted to having misreported smoking quantity, frequency and/or consequences during the study. Factors associated with under- and over-reporting were compared to accurate-reporting. RESULTS: One in 4 adolescent smokers (25.6%) admitted to under-reporting during the study and 14.7% admitted to over-reporting; 10.9% of the adolescents admitted to both under- and over-reporting. Rates of admitted misreporting did not differ between treatment conditions or recruitment site. Compared to accurate-reporting, under- and over-reporting were significantly associated with home smoking environment and the belief among adolescents that the baseline interviewer wanted them to report smoking more or less than they actually smoked. Compared to accurate reporters, over-reporters were more likely to be non-White and to report being concerned with the confidentiality of their responses. CONCLUSIONS: A post-study confidential debriefing questionnaire can be a useful tool for estimating rates of misreporting and examining whether potential differences in misreporting might bias the interpretation of treatment effects. Future studies are needed to thoroughly examine potentially addressable reasons that adolescents misreport their smoking behavior and to develop methods for reducing misreporting.
RCT Entities:
INTRODUCTION: Misreporting smoking behavior is common among younger smokers participating in clinical trials for smoking cessation. This study focused on the prevalence of and factors associated with adolescent misreporting of smoking behaviors within the context of a randomized clinical trial for smoking cessation. METHODS: Adolescent smokers (N=129) participated in a randomized clinical trial that compared two brief interventions for smoking cessation. Following the final (6-month) follow-up, a confidential, self-administered exit questionnaire examined the extent to which participants admitted to having misreported smoking quantity, frequency and/or consequences during the study. Factors associated with under- and over-reporting were compared to accurate-reporting. RESULTS: One in 4 adolescent smokers (25.6%) admitted to under-reporting during the study and 14.7% admitted to over-reporting; 10.9% of the adolescents admitted to both under- and over-reporting. Rates of admitted misreporting did not differ between treatment conditions or recruitment site. Compared to accurate-reporting, under- and over-reporting were significantly associated with home smoking environment and the belief among adolescents that the baseline interviewer wanted them to report smoking more or less than they actually smoked. Compared to accurate reporters, over-reporters were more likely to be non-White and to report being concerned with the confidentiality of their responses. CONCLUSIONS: A post-study confidential debriefing questionnaire can be a useful tool for estimating rates of misreporting and examining whether potential differences in misreporting might bias the interpretation of treatment effects. Future studies are needed to thoroughly examine potentially addressable reasons that adolescents misreport their smoking behavior and to develop methods for reducing misreporting.
Authors: Robin Mermelstein; Suzanne M Colby; Christi Patten; Alexander Prokhorov; Richard Brown; Mark Myers; William Adelman; Karen Hudmon; Paul McDonald Journal: Nicotine Tob Res Date: 2002-11 Impact factor: 4.244
Authors: L A R Stein; Suzanne M Colby; Tracy A O'Leary; Peter M Monti; Damaris J Rohsenow; Anthony Spirito; Suzanne Riggs; Nancy P Barnett Journal: J Drug Educ Date: 2002
Authors: Johanna M Lewis-Esquerre; Suzanne M Colby; Tracy O'Leary Tevyaw; Cheryl A Eaton; Christopher W Kahler; Peter M Monti Journal: Drug Alcohol Depend Date: 2005-07 Impact factor: 4.492
Authors: Neal L Benowitz; John T Bernert; Jonathan Foulds; Stephen S Hecht; Peyton Jacob; Martin J Jarvis; Anne Joseph; Cheryl Oncken; Megan E Piper Journal: Nicotine Tob Res Date: 2020-06-12 Impact factor: 4.244
Authors: Natasha E Wade; Clare E Palmer; Marybel R Gonzalez; Alexander L Wallace; M Alejandra Infante; Susan F Tapert; Joanna Jacobus; Kara S Bagot Journal: Alcohol Date: 2021-01-09 Impact factor: 2.405
Authors: Flora Tzelepis; Christine L Paul; Christopher M Williams; Conor Gilligan; Tim Regan; Justine Daly; Rebecca K Hodder; Emma Byrnes; Judith Byaruhanga; Tameka McFadyen; John Wiggers Journal: Cochrane Database Syst Rev Date: 2019-10-29
Authors: Thomas R Fanshawe; William Halliwell; Nicola Lindson; Paul Aveyard; Jonathan Livingstone-Banks; Jamie Hartmann-Boyce Journal: Cochrane Database Syst Rev Date: 2017-11-17
Authors: Jorien L Treur; Andrea D Rozema; Jolanda J P Mathijssen; Hans van Oers; Jacqueline M Vink Journal: Eur J Epidemiol Date: 2017-12-19 Impact factor: 8.082